C12Y 207/1102
Elongation factor 2 kinase , i.e. eef-2k
Official title: Elongation factor 2 kinase (2.7.11.20), i.e. eEF-2K
C12Y207/1102 (Elongation factor 2 kinase , i.e. eef-2k) appears on 0 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 4
- Assignees
- 3
- Inventors
- 9
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Eukaryotic elongation factor-2 kinase as a cytotoxic t lymphocytes booster30 Jan 2025US 2025/0032593 A1The Texas A&M University System
- Mtor inhibitors and methods of use thereof15 Nov 2018US 2018/0327364 A1Brandeis University
- Kinases as targets for anti-diabetic therapy19 Dec 2013US 2013/0336986 A1Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Regulators of the Interferon-Alpha Receptor 1 (IFNAR1) Chain of the Interferon Receptor19 Jan 2012US 2012/0014911 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.